Details

Autor(en) / Beteiligte

• Ratter-Rieck, Jacqueline M
• Maalmi, Haifa
• Trenkamp, Sandra
• Zaharia, Oana-Patricia
• Rathmann, Wolfgang
• Schloot, Nanette C
• Straßburger, Klaus
• Szendroedi, Julia
• Herder, Christian
• Roden, Michael

Titel

Leukocyte Counts and T-Cell Frequencies Differ Between Novel Subgroups of Diabetes and Are Associated With Metabolic Parameters and Biomarkers of Inflammation

Ist Teil von

• Diabetes (New York, N.Y.), 2021-11, Vol.70 (11), p.2652-2662

Ort / Verlag

United States: American Diabetes Association

Erscheinungsjahr

2021

Quelle

MEDLINE

Beschreibungen/Notizen

• Frequencies of circulating immune cells are altered in those with type 1 and type 2 diabetes compared with healthy individuals and are associated with insulin sensitivity, glycemic control, and lipid levels. This study aimed to determine whether specific immune cell types are associated with novel diabetes subgroups. We analyzed automated white blood cell counts ( = 669) and flow cytometric data ( = 201) of participants in the German Diabetes Study with recent-onset (<1 year) diabetes, who were allocated to five subgroups based on data-driven analysis of clinical variables. Leukocyte numbers were highest in severe insulin-resistant diabetes (SIRD) and mild obesity-related diabetes (MOD) and lowest in severe autoimmune diabetes (SAID). CD4 T-cell frequencies were higher in SIRD versus SAID, MOD, and mild age-related diabetes (MARD), and frequencies of CCR4 regulatory T cells were higher in SIRD versus SAID and MOD and in MARD versus SAID. Pairwise differences between subgroups were partially explained by differences in clustering variables. Frequencies of CD4 T cells were positively associated with age, BMI, HOMA2 estimate of β-cell function (HOMA2-B), and HOMA2 estimate of insulin resistance (HOMA2-IR), and frequencies of CCR4 regulatory T cells with age, HOMA2-B, and HOMA2-IR. In conclusion, different leukocyte profiles exist between novel diabetes subgroups and suggest distinct inflammatory processes in these diabetes subgroups.